660 completed, 220 unknown, 215 recruiting, 130 terminated. 472 Phase 2, 257 Phase 3, 194 Phase 1, 122 Not applicable, 64 Phase 4.
Follow Blood Platelet Disorders: new trials by email Literature Review of Blood Platelet Disorders trials Research Report on Blood Platelet Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids. Ianalumab, Eltrombopag - Primary Immune Thrombocytopenia (ITP) | Phase 2 | Not yet recruiting | Novartis Pharmaceuticals | 36 | 2027-02-08 | 2026-06-25 |
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias RXIM002 - Immune Thrombocytopenia (ITP) | Phase 1 | Not yet recruiting | RiboX Therapeutics Ltd. | 27 | 2027-02-01 | 2026-10-28 |
| Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | Not yet recruiting | Jonsson Comprehensive Cancer Center | 35 | 2027-01-30 | 2026-11-05 |
| WELL-MPN: A Digital Lifestyle App for Patients With MPNs WELL-MPN Digital App - Myeloproliferative Neoplasms (MPNs) | Not applicable | Not yet recruiting | Brigham and Women's Hospital | 75 | 2027-01-01 | 2026-09-29 |
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| A Clinical Study Evaluating the Safety and Preliminary Effectiveness of Induced Pluripotent Stem Cell-derived Platelets in Patients With Thrombocytopenia Caused by Allogeneic Hematopoietic Stem Cell Transplantation iPSC-derived platelets - Thrombocytopenia | Early Phase 1 | Not yet recruiting | Ruijin Hospital | 9 | 2026-12-30 | 2026-10-29 |
| A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA) | Phase 1 / Phase 2 | Not yet recruiting | Cullinan Therapeutics Inc. | 72 | 2026-12-01 | 2026-07-31 |
| Sequential Hetrombopag and Recombinant Human Thrombopoietin for Cancer Therapy-Induced Thrombocytopenia Hetrombopag and recombinant human thrombopoietin, Recombinant Human Thrombopoietin - Thrombocytopenia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Zhengzhou University | 96 | 2026-12-01 | 2026-11-12 |
| Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia Zanubrutinib 80mg/d, High dose dexamethasone, Zanubrutinib 160mg/d - Immune Thrombocytopenia | Phase 2 | Not yet recruiting | Peking University People's Hospital | 90 | 2026-12-01 | 2026-11-12 |
| Study of LusPACercept in Participants With Myelofibrosis Associated Anemia and Thrombocytopenia Luspatercept, Pacritinib - Myelofibrosis | Phase 2 | Not yet recruiting | Case Comprehensive Cancer Center | 50 | 2026-12-01 | 2026-11-13 |
| Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell Cytopenias Avatrombopag - Thrombocytopenia | Phase 2 | Not yet recruiting | University of Virginia | 26 | 2026-11-01 | 2026-10-26 |
| Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation Romiplostim N01 - Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Henan University of Science and Technology | 87 | 2026-11-01 | 2026-09-21 |
| A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia Sutacimig - Thrombasthenia | Phase 3 | Recruiting | Hemab ApS | 76 | 2026-10-27 | 2026-11-13 |
| Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients Laboratory tests TSH, FT3, FT4 ,anti thyroglobulin antibodies, Anti -TPO antibodies - Thyroid Dysfunction, Immune Thrombocytopenic Purpura | Not yet recruiting | Sohag University | 50 | 2026-10-25 | 2026-10-28 | |
| TGD001 Treatment in Thrombotic Microangiopathies TGD001 - Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | TargED Biopharmaceuticals B.V. | 70 | 2026-10-25 | 2026-11-12 |
| Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias Pacritinib, Selinexor - Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 2 | Recruiting | John Mascarenhas | 26 | 2026-10-23 | 2026-10-27 |
| Neonatal Thrombocytopenia in the NICU Thrombocytopenia, Neonatal Thrombocytopenia | Not yet recruiting | Assiut University | 120 | 2026-10-20 | 2026-10-20 | |
| rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures. rhTPO, Placebo - Thrombocytopenia Associated With Chronic Liver Disease | Phase 3 | Recruiting | MIBIO PTE. LTD. | 150 | 2026-10-20 | 2026-11-06 |
| Hetrombopag for Thrombocytopenia in Patients Scheduled for Elective Hepatic Interventional Diagnostic and Therapeutic Procedures: A Clinical Study Hetrombopag, Placebo - Thrombocytopenia, Hepatic Interventional Procedure | Phase 3 | Not yet recruiting | Zhongda Hospital | 108 | 2026-10-15 | 2026-11-09 |
Showing 20 of 1419. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (483) · Thrombocytopenia (415) · Thrombocythemia, Essential (229) · Primary Myelofibrosis (193) · Polycythemia Vera (182) · Myeloproliferative Disorders (160) · Myelodysplastic Syndromes (104) · Leukemia, Myeloid, Acute (100) · von Willebrand Diseases (95) · Leukemia, Myelomonocytic, Chronic (91) · Leukemia, Lymphocytic, Chronic, B-Cell (88) · Leukemia (85) · Multiple Myeloma (85) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (84) · Lymphoma, Non-Hodgkin (73)
Hemic and Lymphatic Diseases (1418) · Hematologic Diseases (1367) · Cytopenia (1010) · Blood Coagulation Disorders (901) · Hemorrhagic Disorders (856) · Pathological Conditions, Signs and Symptoms (807) · Pathologic Processes (794) · Immune System Diseases (648) · Thrombocytopenia (600) · Thrombotic Microangiopathies (590) · Signs and Symptoms (582) · Hemorrhage (560) · Skin Manifestations (550) · Purpura (531)
eltrombopag (105) · romiplostim (53) · Dexamethasone (49) · Rituximab (48) · avatrombopag (43) · Cyclophosphamide (32) · fludarabine phosphate (28) · Peripheral Blood Stem Cell Transplantation (27) · Cyclosporine (25) · Blood Specimen Collection (23) · ruxolitinib (23) · Prednisone (22) · Thrombopoietin (22) · Busulfan (21) · Tacrolimus (20)
Peking University People's Hospital (54) · Shandong University (45) · Institute of Hematology & Blood Diseases Hospital, China (41) · GlaxoSmithKline (28) · Novartis Pharmaceuticals (27) · Amgen (26) · Alexion Pharmaceuticals, Inc. (21) · Assistance Publique - Hôpitaux de Paris (21) · Assiut University (21) · National Heart, Lung, and Blood Institute (NHLBI) (20) · Takeda (20) · M.D. Anderson Cancer Center (17) · University Hospital, Bordeaux (17) · National Cancer Institute (NCI) (16) · Fred Hutchinson Cancer Center (14)
United States (546) · China (285) · France (210) · Italy (175) · United Kingdom (154) · Germany (150) · Spain (120) · Canada (97) · Poland (79) · Australia (76) · Netherlands (73) · Austria (65) · Japan (65) · Belgium (64) · Russia (55)
Lei Zhang, MD (19) · Xiao-Hui Zhang, MD (14) · Xiaohui Zhang, MD (10) · Ming Hou, Dr (6) · John Mascarenhas, MD (5) · Ming Hou (5) · Ming Hou, Dr. (5)
PMID 33783815, PMID 19005182, PMID 19846889, PMID 29958797, PMID 40277027, PMID 19671919, PMID 23738544, PMID 24802773, PMID 29419434, PMID 29674506, PMID 34219224, PMID 24254965, PMID 26231455, PMID 26688484, PMID 33995988, PMID 34724566, PMID 12944568, PMID 17077333, PMID 18242413, PMID 20546023, PMID 21533818, PMID 22067384, PMID 22117897, PMID 22409309, PMID 22494019, PMID 23293082, PMID 23470153, PMID 23492914, PMID 24802775, PMID 25566808, PMID 26480931, PMID 27658437, PMID 27734464, PMID 29042367, PMID 29246923, PMID 29445374, PMID 29536526, PMID 29778606, PMID 30369044, PMID 30992268, PMID 32047671, PMID 32499241, PMID 33031789, PMID 33275766, PMID 33632264, PMID 33881463, PMID 34452956, PMID 34794687, PMID 35030255, PMID 38237075
2023 (19), 2018 (10), 2019 (9), 2014 (7), P01CA108671 (7), 2016 (6), P30CA015083 (6), P30CA006973 (5), U01HL072268 (5), 2009 (4), 2017 (4), 2025 (4), P30CA015704 (4), 2004 (3), P01CA015396 (3)